International Journal of
Medicine and Medical Sciences

  • Abbreviation: Int. J. Med. Med. Sci.
  • Language: English
  • ISSN: 2006-9723
  • DOI: 10.5897/IJMMS
  • Start Year: 2009
  • Published Articles: 535

Full Length Research Paper

Antibacterial activity of Schiff base ligands containing pyridine and disulphide moieties against some chosen human bacterial pathogens

Sabina Jhaumeer Laulloo
  • Sabina Jhaumeer Laulloo
  • Department of Chemistry, Faculty of Science, University of Mauritius, Reduit, Mauritius.
  • Search for this author on:
  • Google Scholar
M. G. Bhowon
  • M. G. Bhowon
  • Department of Chemistry, Faculty of Science, University of Mauritius, Reduit, Mauritius.
  • Search for this author on:
  • Google Scholar
S. Ravikumar
  • S. Ravikumar
  • School of Marine Science, Centre for Marine Pharmacology, Alagappa University, Thondi- 623 409, Ramanathapuram District, Tamil Nadu, India.
  • Search for this author on:
  • Google Scholar
A. Kalaiarasi
  • A. Kalaiarasi
  • School of Marine Science, Centre for Marine Pharmacology, Alagappa University, Thondi- 623 409, Ramanathapuram District, Tamil Nadu, India.
  • Search for this author on:
  • Google Scholar
M. Raja
  • M. Raja
  • Department of Chemistry, Sethupathy Government Arts College, Ramanathapuram, Tamil Nadu, India.
  • Search for this author on:
  • Google Scholar
V. Vijayakumar
  • V. Vijayakumar
  • School of Marine Science, Centre for Marine Pharmacology, Alagappa University, Thondi- 623 409, Ramanathapuram District, Tamil Nadu, India.
  • Search for this author on:
  • Google Scholar


  •  Accepted: 23 April 2013
  •  Published: 01 June 2013

Abstract

The objective of the study was to evaluate the antibacterial activities of N,N’[1,1’-dithiobis(phenylene)]bis(benzyldeneimine), referred to as L1 and o,o’-(N,N-dipicolinyldene) diazadiphenyldisulfide, referred to as L2, containing disulfide moieties against some ophthalmic pathogens (Klebsiella species, Escherichia coli, Streptococcus species, Proteus morganii, Pseudomonas species, Streptococcus pneumoniae, Acinetobacter species, Streptococcus pyogenes and Streptococcus viridans), urinary tract infectious pathogens (P. morganii, E. coli, Pseudomonas spp., Enterobacter species, and Klebsiella spp.) and antibiotic resistant pathogens (Staphylococcus species, Streptococcus, Pseudomonas spp., and Klebsiella spp.) for minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC). The MIC for the ophthalmic pathogens and antibiotic resistant pathogens were found to be 400 to 500 µg/ml, while for the urinary tract infectious pathogens a lower MIC value (200 µg/ml) was obtained. The MBC for the compounds against all the pathogens tested was 400 to 500 µg/ml. The synthesized Schiff L1 and L2 showed the MIC values for all the tested ophthalmic and antibiotic resistant bacterial pathogens more or less similar. Further studies are needed to prove the safe and efficacy needed for these compounds to develop as a drug after completing successful preclinical and clinical tests.

 

Key words: Antibacterial activity, minimum bactericidal concentration (MBC), minimum inhibitory concentration (MIC), N, N’[1,1’-dithiobis(phenylene)]bis(benzyldeneimine), ophthalmic pathogens,  Urinary tract infectious pathogens (UTI), antibiotic resistant pathogens.

Copyright © 2024 Author(s) retain the copyright of this article.

This article is published under the terms of the Creative Commons Attribution License 4.0

Back to Vol. 5 No. 6
Back to articles
SUBSCRIBE TO RSS
SUBMIT MANUSCRIPT
CONFERENCES